Keywords: Novo Nordisk, Tresiba, Japan pricing agreed, Type 1 and 2 diabetes

Novo Nordisk now ready to launch Tresiba in Japan, following pricing accord

Article | 13 February 2013

Print This

Danish insulin giant Novo Nordisk (NOV: N) yesterday announced that it has received approval of the price of Tresiba (insulin ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in